Natalie Sacks, Chief Medical Officer at Harpoon Therapeutics, Inc. (HARP), sold 9,112 shares at $12.06 ($110K) on 2020-04-13, disclosed to the SEC on 2020-04-15.
Open-market sale of $110k HARP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.06 | 4,556 | $55K | 50.0% |
| 2 | $12.06 | 4,556 | $55K | 50.0% |
| Total | $12.06 avg | 9,112 | $110K | 100% |
| Filing → |
| HARP | SELL | 2020-04-17 | $18K | — | Filing → |
| HARP | SELL | 2020-04-08 | $15K | — | Filing → |
| HARP | SELL | 2020-03-18 | $18K | — | Filing → |